Ataxia-telangiectasia gene
AssigneesThe United States of America as represented by the Department of Health and Human Services, Ramot-University of Authority for Applied Research and Industrial Dev. Ltd.
InventorsYosef Shiloh, Danilo A. Tagle, Francis Collins
Life of this patent
Estimating the term…
Abstract
There is provided a purified amino acid sequence selected from the group of Sequence ID No.: 3 and analogs thereof and mutations of Sequence ID No.: 3 which cause ataxia-telangiectasia. Also provided is a purified amino acid sequence as set forth in Sequence ID No.: 3 and analogs thereof.
Claims5
A purified amino acid sequence selected from the group consisting of SEQ ID No:3 and analogs thereof and mutations of SEQ ID No:3 which cause ataxia-telangiectasia.
A purified amino acid sequence as set forth in SEQ ID No:3 and analogs thereof.
Dependencies are inferred from the claim text.